Key result
FUNDC1 regulation exerts context-dependent protective or detrimental effects across ischemic, failing, and metabolic cardiomyopathy models.
Why the study?
The mitophagy receptor FUNDC1 has divergent, context-dependent effects in cardiovascular disease, and the underlying causal mechanisms and experimental inconsistencies remain incompletely defined.
This narrative review synthesizes preclinical evidence demonstrating that FUNDC1-mediated mitophagy and organelle communication have highly context-, cell-type-, and disease-stage-dependent effects in myocardial ischemia/reperfusion injury, heart failure, and metabolic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Context-dependent FUNDC1 effects should not yet guide clinical targeting; leaves open need for flux-validated, cell-specific studies before translation.
Mitochondrial quality-control failure contributes to cardiovascular injury, but the consequences of mitophagy depend on the nature and timing of stress. FUN14 domain-containing protein 1 (FUNDC1) is an outer mitochondrial membrane mitophagy receptor that also regulates mitochondrial dynamics, mitochondria–endoplasmic reticulum contacts, and Ca 2 ⁺ homeostasis. This review synthesizes the regulation of FUNDC1 and critically examines its context-dependent effects in myocardial ischemia/reperfusion injury (MIRI), heart failure and myocardial remodeling, and metabolic cardiomyopathy. In several MIRI and heart-failure models, impaired FUNDC1-associated mitochondrial quality control is linked to injury, whereas excessive or mistimed FUNDC1-associated mitophagy may be detrimental in selected reperfusion and pulmonary vascular settings. In metabolic cardiomyopathy, hyperglycemia-associated FUNDC1–IP3R2 signaling promotes abnormal organelle contacts and mitochondrial Ca 2 ⁺ overload, whereas FUNDC1 deficiency during lipid overload is linked to mitochondrial damage and heightened lipotoxic susceptibility. These apparently divergent effects may reflect differences in cellular context, stress exposure, disease stage, and mitophagy-independent FUNDC1 functions; however, the underlying causal mechanisms remain incompletely defined. We highlight inconsistencies among experimental models and distinguish evidence from direct mitophagy-flux measurements from conclusions based on indirect markers. Given the predominance of preclinical evidence, further mechanistic and translational studies are needed before FUNDC1-directed therapies can be considered for clinical use.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2026) conducted a review in Cardiovascular disease (myocardial ischemia/reperfusion injury, heart failure and myocardial remodeling, and metabolic cardiomyopathy). FUNDC1-mediated mitophagy and mitochondrial homeostasis regulation was evaluated on Mitochondrial quality control, organelle contacts, Ca2+ homeostasis, and cardiovascular injury across experimental models. FUNDC1-mediated mitophagy and organelle contact regulation exert context-dependent protective or detrimental effects across myocardial ischemia/reperfusion, heart failure, and metabolic cardiomyopathy models.
Synapse has enriched 10 related papers. Consider them for comparative context: